Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical Trials

INTRODUCTION: Safety underreporting is a recurrent issue in clinical trials that can impact patient safety and data integrity. Clinical quality assurance (QA) practices used to detect underreporting rely on on-site audits; however, adverse events (AEs) underreporting remains a recurrent issue. In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barmaz, Yves, Ménard, Timothé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278191/
https://www.ncbi.nlm.nih.gov/pubmed/34260043
http://dx.doi.org/10.1007/s40264-021-01094-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278191/
https://www.ncbi.nlm.nih.gov/pubmed/34260043
http://dx.doi.org/10.1007/s40264-021-01094-8

Ejemplares similares